Nicotinamide mononucleotide: a potential effective natural compound against insulin resistance

Signal Transduct Target Ther. 2021 Aug 19;6(1):310. doi: 10.1038/s41392-021-00723-z.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products / therapeutic use*
  • Female
  • Humans
  • Insulin / genetics*
  • Insulin / metabolism
  • Insulin Resistance / genetics*
  • NAD / metabolism
  • Nicotinamide Mononucleotide / therapeutic use*
  • Overweight / drug therapy
  • Overweight / genetics
  • Randomized Controlled Trials as Topic

Substances

  • Biological Products
  • Insulin
  • NAD
  • Nicotinamide Mononucleotide